Facet Logo     About Us
Pipeline
R&D
  News & Investors
Careers
Contact
         
 
  Pipeline
Overview
Daclizumab
Elotuzumab (HuLuc63)
TRU-016
Volociximab (M200)
PDL192
  MoA VOLOCIXIMAB